Cargando…
Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer death in the USA, accounting for ~40,000 deaths annually. The dismal prognosis for PDAC is largely due to its late diagnosis. Currently, the most sensitive diagnosis of PDAC requires invasive procedures, such as endoscopic...
Autores principales: | Cruz-Monserrate, Zobeida, Roland, Christina L., Deng, Defeng, Arumugam, Thiruvengadam, Moshnikova, Anna, Andreev, Oleg A., Reshetnyak, Yana K., Logsdon, Craig D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958716/ https://www.ncbi.nlm.nih.gov/pubmed/24642931 http://dx.doi.org/10.1038/srep04410 |
Ejemplares similares
-
Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding
por: Reshetnyak, Yana K., et al.
Publicado: (2020) -
Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype
por: Fu, Yong, et al.
Publicado: (2015) -
TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
por: Cao, Jia, et al.
Publicado: (2015) -
The Role of Genetic, Metabolic, Inflammatory, and Immunologic Mediators in the Progression of Intraductal Papillary Mucinous Neoplasms to Pancreatic Adenocarcinoma
por: Shockley, Kylie E., et al.
Publicado: (2023) -
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP
por: Moshnikova, Anna, et al.
Publicado: (2022)